MetaADEDB 2.0 @ LMMD
Qlaira
(LRHSUZNWLAJWRT-GAJBHWORSA-N)
Structure
SMILES
N#CC[C@]1(O)CC[C@@H]2[C@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@H]21.CCCCC(=O)O[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O
Molecular Formula:
C43H57NO5
Molecular Weight:
667.916
Log P:
9.1875
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
107.62
CAS Number(s):
307334-58-3
Synonym(s)
1.
Qlaira
External Link(s)
PubChem Compound9874560
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Pregnancy on oral contraceptiveFAERS: 81US FAERS
2Drug ineffectiveFAERS: 44US FAERS
3MetrorrhagiaFAERS: 38US FAERS
4HeadacheFAERS: 31US FAERS
5Urinary tract infectionFAERS: 21US FAERS
6VomitingFAERS: 17US FAERS
7NauseaFAERS: 16US FAERS
8DizzinessFAERS: 14US FAERS
9Abdominal PainFAERS: 12US FAERS
10Ectopic PregnancyFAERS: 11US FAERS
11Pulmonary EmbolismFAERS: 11US FAERS
12Limb discomfortFAERS: 9US FAERS
13PainFAERS: 9US FAERS
14Product use in unapproved indicationFAERS: 9US FAERS
15Drug dose omissionFAERS: 8US FAERS
16MalaiseFAERS: 8US FAERS
17Abnormal withdrawal bleedingFAERS: 7US FAERS
18Cerebrovascular accidentFAERS: 7US FAERS
19HypersensitivityFAERS: 7US FAERS
20LymphadenopathyFAERS: 7US FAERS
21NasopharyngitisFAERS: 7US FAERS
22PregnancyFAERS: 7US FAERS
23AstheniaFAERS: 6US FAERS
24Inappropriate schedule of drug administrationFAERS: 6US FAERS
25AlopeciaFAERS: 5US FAERS
26Blighted ovumFAERS: 5US FAERS
27Chest discomfortFAERS: 5US FAERS
28PruritusFAERS: 5US FAERS
29VertigoFAERS: 5US FAERS
30Abdominal discomfortFAERS: 4US FAERS
31Alanine Aminotransferase IncreasedFAERS: 4US FAERS
32AnxietyFAERS: 4US FAERS
33EndometriosisFAERS: 4US FAERS
34FatigueFAERS: 4US FAERS
35HemiplegiaFAERS: 4US FAERS
36Low birth weight babyFAERS: 4US FAERS
37MyalgiaFAERS: 4US FAERS
38PalpitationsFAERS: 4US FAERS
39Pregnancy on contraceptiveFAERS: 4US FAERS
40Product use issueFAERS: 4US FAERS
41SyncopeFAERS: 4US FAERS
42Visual ImpairmentFAERS: 4US FAERS
43AcneFAERS: 3US FAERS
44AngioedemaFAERS: 3US FAERS
45Aspartate Aminotransferase IncreasedFAERS: 3US FAERS
46Back PainFAERS: 3US FAERS
47Chest PainFAERS: 3US FAERS
48Deep Vein ThrombosisFAERS: 3US FAERS
49Drug exposure during pregnancyFAERS: 3US FAERS
50DyspareuniaFAERS: 3US FAERS
51GastritisFAERS: 3US FAERS
52Maternal exposure during pregnancyFAERS: 3US FAERS
53MenorrhagiaFAERS: 3US FAERS
54NephrolithiasisFAERS: 3US FAERS
55PhlebitisFAERS: 3US FAERS
56Respiratory tract infection viralFAERS: 3US FAERS
57ThrombophlebitisFAERS: 3US FAERS
58Vaginal DischargeFAERS: 3US FAERS
59Vulvovaginal burning sensationFAERS: 3US FAERS
60Abdominal tendernessFAERS: 2US FAERS
61Acute vestibular syndromeFAERS: 2US FAERS
62Adnexa uteri painFAERS: 2US FAERS
63Blood alkaline phosphatase increasedFAERS: 2US FAERS
64Breast discomfortFAERS: 2US FAERS
65Breech PresentationFAERS: 2US FAERS
66CystitisFAERS: 2US FAERS
67Dengue FeverFAERS: 2US FAERS
68Depressed moodFAERS: 2US FAERS
69DiscomfortFAERS: 2US FAERS
70DysuriaFAERS: 2US FAERS
71Ectopic pregnancy under hormonal contraceptionFAERS: 2US FAERS
72EndometritisFAERS: 2US FAERS
73EpistaxisFAERS: 2US FAERS
74Eye painFAERS: 2US FAERS
75Feeling abnormalFAERS: 2US FAERS
76Fibroadenoma of breastFAERS: 2US FAERS
77GastroenteritisFAERS: 2US FAERS
78General physical health deteriorationFAERS: 2US FAERS
79Gestational DiabetesFAERS: 2US FAERS
80Head discomfortFAERS: 2US FAERS
81HyperthyroidismFAERS: 2US FAERS
82Inappropriate schedule of product administrationFAERS: 2US FAERS
83Lip swellingFAERS: 2US FAERS
84Memory impairmentFAERS: 2US FAERS
85Migraine with AuraFAERS: 2US FAERS
86No adverse eventFAERS: 2US FAERS
87Ocular icterusFAERS: 2US FAERS
88Optic NeuritisFAERS: 2US FAERS
89Ovarian RuptureFAERS: 2US FAERS
90Ovulation InductionFAERS: 2US FAERS
91ParaplegiaFAERS: 2US FAERS
92Pelvic PainFAERS: 2US FAERS
93Peripheral swellingFAERS: 2US FAERS
94SalpingitisFAERS: 2US FAERS
95Subcutaneous AbscessFAERS: 2US FAERS
96SwellingFAERS: 2US FAERS
97TachycardiaFAERS: 2US FAERS
98Transaminases increasedFAERS: 2US FAERS
99Ureteral spasmFAERS: 2US FAERS
100Urinary RetentionFAERS: 2US FAERS
101Venous InsufficiencyFAERS: 2US FAERS
102jaundiceFAERS: 2US FAERS
103Abdominal massFAERS: 1US FAERS
104Acute sinusitisFAERS: 1US FAERS
105Adnexa uteri massFAERS: 1US FAERS
106Adverse eventFAERS: 1US FAERS
107Altered state of consciousnessFAERS: 1US FAERS
108Amniotic fluid volume decreasedFAERS: 1US FAERS
109Anembryonic gestationFAERS: 1US FAERS
110Angina PectorisFAERS: 1US FAERS
111AphasiaFAERS: 1US FAERS
112AppendicitisFAERS: 1US FAERS
113ArthralgiaFAERS: 1US FAERS
114ArthropathyFAERS: 1US FAERS
115AsthmaFAERS: 1US FAERS
116Auricular swellingFAERS: 1US FAERS
117Autoimmune thyroiditisFAERS: 1US FAERS
118Back disorderFAERS: 1US FAERS
119Blood cholesterol increasedFAERS: 1US FAERS
120Blood cortisol decreasedFAERS: 1US FAERS
121Blood glucose fluctuationFAERS: 1US FAERS
122Blood glucose increasedFAERS: 1US FAERS
123Blood urine presentFAERS: 1US FAERS
124Borderline Personality DisorderFAERS: 1US FAERS
125Breast cancer stage IIIFAERS: 1US FAERS
126Breast tendernessFAERS: 1US FAERS
127BronchiolitisFAERS: 1US FAERS
128BronchitisFAERS: 1US FAERS
129Burning sensationFAERS: 1US FAERS
130Cardiac ArrestFAERS: 1US FAERS
131Cardiac discomfortFAERS: 1US FAERS
132Cardiac valve ruptureFAERS: 1US FAERS
133CataractFAERS: 1US FAERS
134Cerebral InfarctionFAERS: 1US FAERS
135Cerebral ThrombosisFAERS: 1US FAERS
136Cervical polypFAERS: 1US FAERS
137ChillsFAERS: 1US FAERS
138ChromaturiaFAERS: 1US FAERS
139Chronic tonsillitisFAERS: 1US FAERS
140ConstipationFAERS: 1US FAERS
141CraniectomyFAERS: 1US FAERS
142CystFAERS: 1US FAERS
143Deficiency of bile secretionFAERS: 1US FAERS
144Degeneration of uterine leiomyomaFAERS: 1US FAERS
145Depression suicidalFAERS: 1US FAERS
146Dry skinFAERS: 1US FAERS
147Embolic strokeFAERS: 1US FAERS
148EmbolismFAERS: 1US FAERS
149Endometrial HyperplasiaFAERS: 1US FAERS
150Endometrial hypertrophyFAERS: 1US FAERS
151EnterocolitisFAERS: 1US FAERS
152Epigastric discomfortFAERS: 1US FAERS
153EpilepsyFAERS: 1US FAERS
154ErythemaFAERS: 1US FAERS
155Eye irritationFAERS: 1US FAERS
156Facial PainFAERS: 1US FAERS
157Fibrin D dimer increasedFAERS: 1US FAERS
158FibromyalgiaFAERS: 1US FAERS
159Flank PainFAERS: 1US FAERS
160FlatulenceFAERS: 1US FAERS
161Focal Nodular HyperplasiaFAERS: 1US FAERS
162Genital abscessFAERS: 1US FAERS
163Genital contusionFAERS: 1US FAERS
164Hepatic EncephalopathyFAERS: 1US FAERS
165HepatitisFAERS: 1US FAERS
166Hormone level abnormalFAERS: 1US FAERS
167Human chorionic gonadotropin increasedFAERS: 1US FAERS
168HyperandrogenismFAERS: 1US FAERS
169Hypertensive crisisFAERS: 1US FAERS
170HypertrichosisFAERS: 1US FAERS
171HyperventilationFAERS: 1US FAERS
172HypohidrosisFAERS: 1US FAERS
173HypospadiasFAERS: 1US FAERS
174HypotensionFAERS: 1US FAERS
175Imminent abortionFAERS: 1US FAERS
176Immune thrombocytopenic purpuraFAERS: 1US FAERS
177Impaired work abilityFAERS: 1US FAERS
178ImpatienceFAERS: 1US FAERS
179InfectionFAERS: 1US FAERS
180InfertilityFAERS: 1US FAERS
181Intentional product use issueFAERS: 1US FAERS
182Intestinal ObstructionFAERS: 1US FAERS
183Intracranial AneurysmFAERS: 1US FAERS
184Invasive Lobular Breast CarcinomaFAERS: 1US FAERS
185Joint swellingFAERS: 1US FAERS
186LeukocytosisFAERS: 1US FAERS
187Limb operationFAERS: 1US FAERS
188Maternal exposure before pregnancyFAERS: 1US FAERS
189Medication ErrorFAERS: 1US FAERS
190Metabolic acidosisFAERS: 1US FAERS
191Mixed Connective Tissue DiseaseFAERS: 1US FAERS
192MonoplegiaFAERS: 1US FAERS
193Mood swingsFAERS: 1US FAERS
194Muscle FatigueFAERS: 1US FAERS
195Neonatal aspirationFAERS: 1US FAERS
196NephritisFAERS: 1US FAERS
197NervousnessFAERS: 1US FAERS
198Night sweatsFAERS: 1US FAERS
199OmphalorrhexisFAERS: 1US FAERS
200Oropharyngeal blisteringFAERS: 1US FAERS
201OsteochondrosisFAERS: 1US FAERS
202Ovarian enlargementFAERS: 1US FAERS
203Pancreatic enlargementFAERS: 1US FAERS
204PancreatitisFAERS: 1US FAERS
205ParesisFAERS: 1US FAERS
206Pelvic Inflammatory DiseaseFAERS: 1US FAERS
207Pelvic discomfortFAERS: 1US FAERS
208Performance status decreasedFAERS: 1US FAERS
209Peripheral venous diseaseFAERS: 1US FAERS
210PetechiaeFAERS: 1US FAERS
211PharyngitisFAERS: 1US FAERS
212PhotophobiaFAERS: 1US FAERS
213Pleuritic painFAERS: 1US FAERS
214PneumoniaFAERS: 1US FAERS
215Premenstrual syndromeFAERS: 1US FAERS
216Procedural complicationFAERS: 1US FAERS
217Product prescribing issueFAERS: 1US FAERS
218PyelonephritisFAERS: 1US FAERS
219Retinal DetachmentFAERS: 1US FAERS
220Retinal vascular thrombosisFAERS: 1US FAERS
221Ruptured cerebral aneurysmFAERS: 1US FAERS
222SchizophreniaFAERS: 1US FAERS
223Scoliosis surgeryFAERS: 1US FAERS
224SepsisFAERS: 1US FAERS
225Sex hormone binding globulin increasedFAERS: 1US FAERS
226Sinus TachycardiaFAERS: 1US FAERS
227SinusitisFAERS: 1US FAERS
228Sjogren's SyndromeFAERS: 1US FAERS
229SomnolenceFAERS: 1US FAERS
230Splenic InfarctionFAERS: 1US FAERS
231StressFAERS: 1US FAERS
232Sudden Visual LossFAERS: 1US FAERS
233Suspected counterfeit productFAERS: 1US FAERS
234TeratomaFAERS: 1US FAERS
235Therapeutic response unexpectedFAERS: 1US FAERS
236TinnitusFAERS: 1US FAERS
237TonsillitisFAERS: 1US FAERS
238TremorFAERS: 1US FAERS
239Unevaluable eventFAERS: 1US FAERS
240Urogenital infection fungalFAERS: 1US FAERS
241Urticarial vasculitisFAERS: 1US FAERS
242UrticariaFAERS: 1US FAERS
243Uterine PolypFAERS: 1US FAERS
244Vascular fragilityFAERS: 1US FAERS
245Ventricular arrhythmiaFAERS: 1US FAERS
246Vestibular NeuronitisFAERS: 1US FAERS
247VitiligoFAERS: 1US FAERS
248Vulvovaginal drynessFAERS: 1US FAERS
249Vulvovaginal erythemaFAERS: 1US FAERS
250Vulvovaginal mycotic infectionFAERS: 1US FAERS
251Vulvovaginal painFAERS: 1US FAERS
252Vulvovaginal pruritusFAERS: 1US FAERS
253VulvovaginitisFAERS: 1US FAERS
254Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
255fibromaFAERS: 1US FAERS
256nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.